BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8969375)

  • 21. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E; Am Holen E; Tangen G; Ringdal MA
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion after coronary artery bypass surgery: the impact of heparin-bonded circuits.
    Mahoney CB; Lemole GM
    Eur J Cardiothorac Surg; 1999 Aug; 16(2):206-10. PubMed ID: 10485422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case-controlled evaluation of the Medtronic Resting Heart System compared with conventional cardiopulmonary bypass in patients undergoing isolated coronary artery bypass surgery.
    Nozohoor S; Johnsson P; Scicluna S; Wallentin P; Andell E; Nilsson J
    Interact Cardiovasc Thorac Surg; 2012 May; 14(5):599-604. PubMed ID: 22286599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective randomized trial of Duraflo II heparin-coated circuits in cardiac reoperations.
    McCarthy PM; Yared JP; Foster RC; Ogella DA; Borsh JA; Cosgrove DM
    Ann Thorac Surg; 1999 May; 67(5):1268-73. PubMed ID: 10355394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction.
    Heyer EJ; Lee KS; Manspeizer HE; Mongero L; Spanier TB; Caliste X; Esrig B; Smith C
    J Cardiothorac Vasc Anesth; 2002 Feb; 16(1):37-42. PubMed ID: 11854876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of on-pump coronary bypass using heparin-bonded circuits and reduced anti-coagulation compare favorably with off-pump approach.
    O'Gara PJ; Natarajan V; Lilly K; Husain A; Shapira OM; Shemin RJ
    Perfusion; 2002 Mar; 17(2):91-4. PubMed ID: 11958309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of autologous fresh frozen plasma to reduce blood loss and transfusion requirements in coronary artery bypass surgery.
    Kasper SM; Giesecke T; Limpers P; Sabatowski R; Mehlhorn U; Diefenbach C
    Anesthesiology; 2001 Jul; 95(1):81-6; discussion 6A. PubMed ID: 11465588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redo sternotomy for cardiac reoperations using peripheral heparin-bonded cardiopulmonary bypass circuits without systemic heparinization: technique and results.
    Singh AK; Stearns G; Maslow A; Feng WC; Schwartz C
    J Cardiothorac Vasc Anesth; 2011 Apr; 25(2):347-52. PubMed ID: 20801057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Closed, phosphorylcholine-coated circuit and reduction of systemic heparinization for cardiopulmonary bypass: the intraoperative ECMO concept.
    Ranucci M; Pazzaglia A; Isgrò G; Cazzaniga A; Ditta A; Boncilli A; Cotza M; Carboni G; Brozzi S; Bonifazi C
    Int J Artif Organs; 2002 Sep; 25(9):875-81. PubMed ID: 12403404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation.
    Kuitunen AH; Heikkilä LJ; Salmenperä MT
    Ann Thorac Surg; 1997 Feb; 63(2):438-44. PubMed ID: 9033316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.
    Südkamp M; Mehlhorn U; Reza Raji M; Hekmat K; Easo J; Geissler HJ; Sindhu D; de Vivie R
    Thorac Cardiovasc Surg; 2002 Feb; 50(1):5-10. PubMed ID: 11847596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting.
    Øvrum E; Tangen G; Tølløfsrud S; Skeie B; Ringdal MA; Istad R; Øystese R
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1145-9. PubMed ID: 20709334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery.
    Kreisler KR; Vance RA; Cruzzavala J; Mahnken JD
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):608-11. PubMed ID: 16202894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of biocompatible perfusion strategy in a contemporary series of patients undergoing coronary artery bypass grafting - a two-center study.
    Shapira OM; Korach A; Pinaud F; Dabah A; Bao Y; Corbeau JJ; de Brux JL; Baufreton C
    J Cardiothorac Surg; 2014 Dec; 9():196. PubMed ID: 25519179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.
    Aldea GS; Soltow LO; Chandler WL; Triggs CM; Vocelka CR; Crockett GI; Shin YT; Curtis WE; Verrier ED
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):742-55. PubMed ID: 11986603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.